Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 in the study record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the page history. This update appears to be a metadata/version change rather than a substantive change to the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision v3.4.3 was added to the history, replacing v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history shows a new revision entry (v3.4.2) and the deletion of the previous revision entry (v3.4.1). This updates the audit trail displayed on the page but does not change study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page history shows only a minor update to the revision list (v3.4.1 added and v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe UI adds a glossary toggle, shows color-coded additions (green) and deletions (red), and updates the revision label to v3.4.0 with a capitalization change for 'No FEAR Act Data'.SummaryDifference0.6%

Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.